Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Quantum Biopharma Ltd urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/23/2026.









